Health Canada Conducting Safety Review of Breastfeeding Drug

Tuesday, 31 January 2023 16:45

By Linda Morgan

Health Canada looking into claims that Domperidone can cause severe psychological reaction when some women stop using the drug

Health Canada is conducting a safety review on the drug Domperidone.

The medication is approved in Canada for gastrointestinal symptoms, but is frequently prescribed off-label to increase breastmilk supply.

The organization says it's looking into reports that some mothers suffered psychiatric symptoms after they stopped taking the drug.

The FDA has banned Domperidone in the US due to potential cardiac side effects.

Officials say when the drug is used for lactation, it's often prescribed in doses higher than approved by Health Canada.

More from Local News

Province Investing Against Invasive Species

The $2-million will help the Niagara region
Niagara Driver Charged with Drug Impairment

OPP say this happened on Highway 17, when a car was seen weaving all over the road
Welland Man Arrested for Child Porn

Police say they noticed child sexual abuse material shared on a social media page early this month
28 More Doctors Hired in Niagara

The region and Niagara Health coordinating new partnership to find even more doctors
Killed Police Officers Honoured by NRP

Police Chief praised Niagara members for standing at attention in 'pounding rain'
Niagara Wineries Shuttle Service Possible

The CUTRIC hopes the province supports helping people move among wineries
Canal Days Vendors Warned of Scams

The City of Port Colborne says criminals are sending fraud emails for payment
Niagara Falls Exploring Hub to Help Homeless

Former CAO Ken Todd has been meeting with community groups